Oncology Pharmacy
Oncology Pharmacy provides cancer patients with evidence-based, patient-centered medication therapy management and directs patient care, including treatment assessment and monitoring for potential adverse drug reactions and interactions. Researchers are developing targeted drug delivery systems that can deliver cancer drugs directly to tumors, while sparing healthy cells. This approach could potentially reduce side effects and improve treatment outcomes.
Immunotherapy is an emerging field in oncology that involves using the patient's immune system to fight cancer. Recent studies have focused on developing new immunotherapies, improving existing therapies, and identifying biomarkers that can predict response to treatment. Personalized medicine is an approach that involves tailoring medical treatments to individual patients based on their genetic makeup, lifestyle, and environment. In oncology pharmacy, personalized medicine is being used to develop targeted therapies for specific types of cancer, such as lung cancer and melanoma.
Combination therapy involves using multiple drugs or treatments to attack cancer cells from different angles. Recent research has focused on identifying the most effective combinations of drugs, and on developing new drugs that can be used in combination therapy. Drug resistance is a major challenge in oncology pharmacy, as cancer cells can become resistant to chemotherapy and other treatments. Recent studies have focused on understanding the mechanisms of drug resistance and on developing new strategies to overcome it, such as using combination therapy and immunotherapy.
- Chemotherapy
- Targeted therapies
- Immunotherapy
- Oncology compounding
- Pediatric oncology
- Palliative care
- Oncology pharmacy administration